| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.066 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |